1. Home
  2. HNST vs SPRY Comparison

HNST vs SPRY Comparison

Compare HNST & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Honest Company Inc.

HNST

The Honest Company Inc.

N/A

Current Price

$4.92

Market Cap

585.8M

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$5.59

Market Cap

509.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HNST
SPRY
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
585.8M
509.4M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
HNST
SPRY
Price
$4.92
$5.59
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$3.05
$40.00
AVG Volume (30 Days)
2.6M
2.2M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$371,317,000.00
$84,278,000.00
Revenue This Year
N/A
$87.40
Revenue Next Year
$5.93
$81.64
P/E Ratio
$55.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$4.91
52 Week High
$5.84
$15.09

Technical Indicators

Market Signals
Indicator
HNST
SPRY
Relative Strength Index (RSI) 64.08 38.03
Support Level $3.22 $4.91
Resistance Level $5.84 $8.61
Average True Range (ATR) 0.28 0.40
MACD 0.09 0.13
Stochastic Oscillator 57.74 52.73

Price Performance

Historical Comparison
HNST
SPRY

About HNST The Honest Company Inc.

The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: